XML 40 R28.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Quarterly Consolidated Financial Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]  
Summary of Unaudited Quarterly Results of Operations

The following is a summary of the unaudited quarterly results of operations for the years ended December 31, 2020 and 2019:

 

 

 

2020

 

 

 

First

Quarter

 

 

Second

Quarter

 

 

Third

Quarter

 

 

Fourth

Quarter

 

 

 

(In thousands, except per share amounts)

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net product sales

 

$

25,400

 

 

$

22,668

 

 

$

19,965

 

 

$

20,605

 

Cost of product sales

 

 

(10,622

)

 

 

(9,005

)

 

 

(7,170

)

 

 

(9,392

)

Gross Profit

 

 

14,778

 

 

 

13,663

 

 

 

12,795

 

 

 

11,213

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

36,894

 

 

 

44,004

 

 

 

49,182

 

 

 

44,453

 

General and administrative

 

 

10,422

 

 

 

9,819

 

 

 

9,482

 

 

 

12,503

 

Sales and marketing

 

 

20,196

 

 

 

15,589

 

 

 

12,515

 

 

 

15,553

 

Loss from operations

 

 

(52,734

)

 

 

(55,749

)

 

 

(58,384

)

 

 

(61,296

)

Other income (expense), net

 

 

1,155

 

 

 

559

 

 

 

156

 

 

 

(985

)

Net loss

 

$

(51,579

)

 

$

(55,190

)

 

$

(58,228

)

 

$

(62,281

)

Basic and diluted net loss per share

 

$

(0.57

)

 

$

(0.61

)

 

$

(0.64

)

 

$

(0.68

)

 

 

 

 

2019

 

 

 

First

Quarter

 

 

Second

Quarter

 

 

Third

Quarter

 

 

Fourth

Quarter

 

 

 

(In thousands, except per share amounts)

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net product sales

 

$

31,602

 

 

$

36,659

 

 

$

42,624

 

 

$

35,083

 

Cost of product sales

 

 

(14,962

)

 

 

(13,588

)

 

 

(17,195

)

 

 

(15,874

)

Gross Profit

 

 

16,640

 

 

 

23,071

 

 

 

25,429

 

 

 

19,209

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

42,972

 

 

 

41,425

 

 

 

34,708

 

 

 

48,277

 

General and administrative

 

 

9,648

 

 

 

9,778

 

 

 

8,597

 

 

 

9,874

 

Sales and marketing

 

 

28,720

 

 

 

23,647

 

 

 

16,977

 

 

 

20,420

 

Loss from operations

 

 

(64,700

)

 

 

(51,779

)

 

 

(34,853

)

 

 

(59,362

)

Other income, net

 

 

1,688

 

 

 

1,557

 

 

 

1,258

 

 

 

1,442

 

Net loss

 

$

(63,012

)

 

$

(50,222

)

 

$

(33,595

)

 

$

(57,920

)

Basic and diluted net loss per share

 

$

(0.80

)

 

$

(0.63

)

 

$

(0.42

)

 

$

(0.65

)